General Surgery · Merrillville, IN
NPI
1770610180
Since 2007
Specialty
General Surgery
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
7863 Broadway, Suite 135
Merrillville, IN, 46410
Phone (219) 736-2047
Groups this clinician bills Medicare through
Medicare paid, 2024
$170K
3,300 services
Medicare patients, 2024
52
Average age 70
Drug cost, 2024
$445K
1,534 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Demetrios Katsaros was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,697 times for 11 patients. In total Demetrios Katsaros billed 3,300 services in 38 codes, and Medicare paid $170K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,697 | 11 | $4.96 | $13K |
| 15788 Skin | Office | 96 | 45 | $261.99 | $25K |
| 15792 Skin | Office | 93 | 45 | $238.52 | $22K |
| 15793 Skin | Office | 86 | 40 | $334.92 | $29K |
| 15789 Skin | Office | 85 | 39 | $384.86 | $33K |
| 99214 Office E&M - Established | Office | 65 | 34 | $90.44 | $5,879 |
| 64615 Musculoskeletal | Office | 27 | 13 | $100.08 | $2,702 |
| 17108 Destruction Skin Lesion | Office | 25 | 19 | $454.50 | $11K |
| 36410 Vascular | Office | 21 | 19 | $10.08 | $212 |
| 17107 Destruction Skin Lesion | Office | 14 | 13 | $325.91 | $4,563 |
By year: 2022 $191K for 2,419 services; 2023 $194K for 4,133 services; 2024 $170K for 3,300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Demetrios Katsaros prescribed most often to Medicare patients was Alprazolam, with 119 prescriptions and refills. In total Demetrios Katsaros wrote 1,534 Medicare prescriptions that cost $445K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 119 | 121 | 12 | $812 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 88 | 88 | 15 | $1,938 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 81 | 81 | 11 | $4,083 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 53 | 53 | 21 | $360 |
| Botox Onabotulinumtoxina | 49 | 119 | 17 | $63K |
| Simvastatin Generic | 49 | 123 | 16 | $469 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 41 | 47 | Under 11 | $1,294 |
| Tramadol Hcl Generic | 37 | 37 | Under 11 | $196 |
| Furosemide Generic | 33 | 68 | Under 11 | $267 |
| Amlodipine Besylate Generic | 32 | 92 | 13 | $256 |
| Ondansetron Odt Ondansetron | 31 | 31 | Under 11 | $510 |
| Diazepam Generic | 31 | 31 | Under 11 | $107 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 30 | 30 | Under 11 | $573 |
| Gabapentin Generic | 28 | 44 | Under 11 | $309 |
| Potassium Chloride Generic | 27 | 47 | Under 11 | $728 |
Brand drugs: 216 claims; generic drugs: 1,318 claims; opioid claims: 223.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Demetrios Katsaros were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.